Our latest research results just got published as a paper in Biomacromolecules.
Congratulations to the joint first authors, Matthias and Vinod from our group and everyone else involved in bringing this project to life!


The paper describes the preparation of a protein–polysaccharide conjugate by covalent conjugation of the enzyme horseradish peroxidase (HRP) with a polysaccharide (acetalated dextran (AcDex) via a thiol exchange reaction. The resulting degradable bioconjugate shows a dual-responsive behavior in acidic and reductive environments and can release drugs in a controlled way.

We show, that in slightly acidic conditions, the micellar nanoparticles disassemble and release an encapsulated prodrug (IAA). The conjugated enzyme then has the chance to react and activate the prodrug by oxidation into cytotoxic radicals, which leads to cellular death. The results indicate that this novel biohybrid conjugate has great potential to be used as a novel approach in enzyme prodrug therapy for cancer treatment.

“Dual-Responsive Enzyme–Polysaccharide Conjugate as a Nanocarrier System for Enzyme Prodrug Therapy”
M. Konhäuser, V. K. Kannaujiya, J. Kaltbeitzel, P. Winterwerber, E. Böhm, B. Breitenbach, P. R. Wich
Biomacromolecules, 2023, 24, 2138−2148. (DOI: 10.1021/acs.biomac.3c00031)

#UNSW #UNSWEngineering #UNSWChemEng #WichLab #Biomacromolecules

Dual-Responsive Enzyme–Polysaccharide Conjugate as a Nanocarrier System for Enzyme Prodrug Therapy Matthias Konhäuser, Vinod Kumar Kannaujiya, Jonas Kaltbeitzel, Pia Winterwerber, Elena Böhm, Benjamin Breitenbach, and Peter R. Wich* Cite this: Biomacromolecules 2023, 24, 5, 2138–2148 Publication Date:April 20, 2023 https://doi.org/10.1021/acs.biomac.3c00031 Copyright © 2023 American Chemical Society






Leave a reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.